Pelage Pharmaceutical raised $14M in a Series A-1 funding led by GV to accelerate its Phase 2 clinical program for hair loss treatments.
Amount Raised
$14 Million
Round Type
Series A
Investors
Description
Pelage Pharmaceutical, a clinical-stage regenerative medicine company, raised $14M in Series A-1 funding. The funds will be used to speed up its Phase 2 clinical program for treating hair loss, specifically targeting androgenetic alopecia and chemotherapy-induced alopecia.
Quick answer
Pelage Pharmaceuticals raised $14 Million in a Series A round, dated August 13, 2024. Investors: GV. Pelage Pharmaceuticals is based in Los Angeles, California, United States.
- How much did Pelage Pharmaceuticals raise?
- Pelage Pharmaceuticals raised $14 Million in a Series A round on August 13, 2024.
- Who invested in Pelage Pharmaceuticals?
- GV is named as investors in this round.
- What does Pelage Pharmaceuticals do?
- Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing first-in-class treatments for hair loss.
- Where is Pelage Pharmaceuticals based and how big is it?
- Pelage Pharmaceuticals is based in Los Angeles, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at Pelage Pharmaceuticals?
- Fundz holds 1 contact at Pelage Pharmaceuticals, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Pelage Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Beyond Air raised $21M on September 26, 2024.
- Helaina Inc raised $45M (Series B) on September 25, 2024.
- Redcliffe Labs raised $42M (Series C) on September 20, 2024.
- Nuo Therapeutics raised $849K (Seed) on September 19, 2024.
- Vaccinex raised $200K (Seed) on September 18, 2024.
- Hyalex Orthopaedics raised $16M on September 17, 2024.
Who to call at Pelage Pharmaceuticals, and when
A new round usually means Pelage Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pelage Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pelage Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pelage Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pelage Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPelage Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.